Nancy C. Broadbent

Nancy C. Broadbent is a declared insider at 2 companies; the most frequent names are Collagenex Pharmaceuticals Inc and Orthovita Inc. Over a trading history stretching from 15 June 2006 to 24 June 2011, the count stands at 17 filings.

On the open market, the record shows 3 purchases worth €252k and 7 sales worth €431k. On balance, insiders were net sellers of €179k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 option exercises.

A typical purchase (the median) is worth €94k.

The newest entry dates from 28 June 2011: a transaction of €283k, in Orthovita Inc. The latest purchase dates back some time: it was published 6,193 days ago, on 9 November 2009. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.